1. Product Specifications & Comparative Analysis

2. Key Applications

Therapeutic Uses

• Primary treatment for herpes simplex keratitis (ocular viral infections)
• Inhibitor of orthopoxvirus replication
• Veterinary antiviral applications (e.g., feline herpesvirus type 1)

Research Applications

• DNA polymerase inhibition studies
• Viral replication mechanism analysis
• Reference standard in pharmaceutical QC (USP/EP compliance)

3. Usage Scenarios

Ophthalmic Formulation

0.1% ophthalmic solution applied topically every 1-2 hours during acute phase

Laboratory Protocol

1. Prepare 10 mM stock solution in DMSO
2. Dilute in cell culture medium to working concentration
3. Apply to infected cell lines for 48-72 hours

4. Client Case Studies

Case 1: Pharmaceutical Manufacturer

Client: North China Pharmaceutical Group
Application: USP-grade reference standard production
Outcome: Achieved 99.8% purity for regulatory submissions

Case 2: Veterinary Research Institute

Client: Shenzhen Veterinary Medicine Center
Application: FHV-1 treatment optimization
Outcome: Reduced viral load by 89% in clinical trials

5. Inquiry & Technical Support

For product specifications, COA, or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826

Quality Assurance

• USP/EP certified batches available
• HPLC & NMR analytical reports provided
• Custom synthesis services